Fast cholinergic neurotransmission between superior cervical ganglion neurons (SCGNs) in cell culture is initiated by N-type Ca 2؉ currents through Cav2.2 channels. To test the ability of different Ca 2؉ -channel subtypes to initiate synaptic transmission in these cells, SCGNs were injected with cDNAs encoding Ca v1.2 channels, which conduct L-type currents, Ca v2.1 channels, which conduct P͞Q-type Ca 2؉ currents, and Ca v 2.3 channels, which conduct R-type Ca 2؉ currents. Exogenously expressed Cav2.1 channels were localized in nerve terminals, as assessed by immunocytochemistry with subtype-specific antibodies, and these channels effectively initiated synaptic transmission. Injection with cDNA encoding Ca v2.3 channels yielded a lower level of presynaptic labeling and synaptic transmission, whereas injection with cDNA encoding Ca v1.2 channels resulted in no presynaptic labeling and no synaptic transmission. Our results show that exogenously expressed Ca 2؉ channels can mediate synaptic transmission in SCGNs and that the specificity of reconstitution of neurotransmission (Ca v2.1 > Cav2.3 Ͼ Ͼ Cav1.2) follows the same order as in neurons in vivo. The specificity of reconstitution of neurotransmission parallels the specificity of trafficking of these Ca v channels to nerve terminals.
lectrophysiological and pharmacological studies have defined a diverse array of native Ca 2ϩ currents having different functions in neurons (1, 2) . Voltage-gated Ca 2ϩ channels are complexes of a pore-forming ␣ 1 subunit with associated ␣ 2 ␦, ␤, and ␥ subunits (3) (4) (5) . ␣ 1 subunits can be divided into three families based on structure and function (6) . Ca 2ϩ channels having ␣ 1 subunits of the Ca v 1 family conduct L-type Ca 2ϩ currents (7, 8) , which are important for Ca 2ϩ -dependent regulation of enzyme activity and gene transcription in neurons (9) (10) (11) . Ca 2ϩ channels having ␣ 1 subunits of the Ca v 2 family conduct N-, P͞Q-, and R-type Ca 2ϩ currents (12) (13) (14) (15) , which initiate synaptic transmission in nerve terminals and integrate synaptic signals in cell bodies and dendrites of neurons (16) (17) (18) (19) (20) . Ca 2ϩ channels having ␣ 1 subunits of the Ca v 3 family generate T-type Ca 2ϩ currents, which shape action potentials and generate repetitive firing patterns in neuronal cell bodies and dendrites (21) (22) (23) .
In the central nervous system, excitatory neurotransmitter release is mediated cooperatively by N-, P͞Q-, and R-type Ca 2ϩ currents (1, (18) (19) (20) 24) . In contrast, neurotransmission in sympathetic ganglion neurons is initiated exclusively by N-type Ca 2ϩ currents (25, 26) . These neurons have substantial N-type and L-type Ca 2ϩ currents in their cell bodies (27, 28) , but P͞Q-type Ca 2ϩ currents sensitive to -agatoxin IVA are not observed (29, 30) . The molecular basis for the specific role of Ca v 2 channels in fast neurotransmission is not well understood. Methods to analyze the function of exogenously expressed Ca 2ϩ channels in synaptic transmission would be valuable in addressing these questions. Here we describe functional expression of exogenous Ca v 1.2, Ca v 2.1, and Ca v 2.3 channels in superior cervical ganglion neurons (SCGNs) and show that Ca v 2.1 is most effective in nerve-terminal localization and synaptic transmission, Ca v 2.3 is less effective, and Ca v 1.2 is ineffective. Evidently, these Ca v 2 subunits contain the information within them for selective expression, targeting to nerve terminals, and function in synaptic transmission, whereas Ca v 1.2 does not. (7, 32) ] was constructed in pZEM229. For SCGNexpression studies, ␣ 1 subunit cDNA was prepared via Quantum Maxiprep (Bio-Rad) and resuspended in distilled deionized water. Plasmid DNA for all constructs was prepared with Quantum Maxiprep (Bio-Rad). For SCGN-expression experiments, cDNA concentrations of 3-6 mg͞ml in sterile distilled deionized water were used, with shipment on dry ice and storage at Ϫ80°C until use.
Experimental Procedures Preparation of
cDNA Injection. SCGNs cells from 7-day-postnatal rats were prepared as described (25, 33) . cDNA constructs in distilled deionized water were dissolved in the suction pipette solution (150 mM potassium acetate͞5 mM MgATP͞10 mM Hepes, pH 7.35) (25, 33) . The cDNAs were introduced into the nucleus of SCGNs by diffusion from a glass pipette (40-to 60-M⍀ tip resistance) with hand pressure applied to a syringe connected to the injection pipette. The concentration of cDNAs in the injection pipette was 0.275 mg͞ml. Dextran fluorescein (10 kDa, Molecular Probes) was introduced in the pipette solution to monitor cDNA entry into nuclei (34): 5% for ␣ 1 2.1 cDNA or 7.5% for other cDNAs. After incubation at 37°C͞5% CO 2 in minimal essential medium supplemented with 10% FCS͞5% horse serum͞1% penicillin-streptomycin͞25 ng/ml nerve growth factor for 20-24 h, injected neurons were identified with an inverted microscope (Diaphot 300, Nikon) equipped with an epifluorescence unit and Arugas͞HiSCA (Hamamatsu Photonics, Ichinocho, Japan).
Antibodies. CNA4 is a glutathione S-transferase fusion protein containing amino acids 410-482 from the intracellular loop between domains I and II of Ca v 2.1, a sequence common to several Ca v 2.1 isoforms. Production and purification of CNA4 fusion protein and anti-CNA4 antibodies were performed as described (35) . The anti-CNA5 antibody recognizes the intracellular loop between domains II and III of the ␣ 1 subunit of the rbA isoform of Ca v 2.1 channels (35 to specifically recognize these Ca 2ϩ -channel isoforms (35) (36) (37) (38) (39) (40) . The antisynaptophysin antibody was purchased from Chemicon, and Cy5-labeled avidin D was obtained from Jackson ImmunoResearch.
Immunocytochemistry. SCGNs were cultured and injected in Tokyo, fixed in acetone for 5 min or 4% paraformaldehyde for 30 min, rinsed three times in PBS for 5 min, frozen for shipment to Seattle on dry ice, and stored at Ϫ80°C. The SCGN cultures were allowed to warm to room temperature before processing. Both the SCGN and tsA-201 cell cultures were rinsed with 0.1 M phosphate buffer for 5 min, fixed in 4% paraformaldehyde for 20 min, rinsed in 0.1 M phosphate buffer for 5 min, rinsed in 0.1 M Tris buffer for 15 min, rinsed in Tris-buffered saline (TBS) for 15 min, and then blocked for 1 h by using TBS containing 5% nonfat milk and 5% normal goat serum. The cultures were incubated with anti-CNA4 (diluted 1:15), anti-CNA5 (diluted 1:15), anti-CNB2 (diluted 1:15), anti-CNC1 (diluted 1:15), or anti-CNE1 antibodies (diluted 1:15) overnight at room temperature. The antibodies were diluted in TBS containing 5% nonfat milk, 5% normal goat serum, and 0.03% Triton X-100. The cultures then were rinsed in TBS for 30 min, incubated in biotinylated goat anti-rabbit IgG (Vector Laboratories, diluted 1:300) for 2 h at room temperature, rinsed in TBS for 30 min, incubated in avidin D Texas red or avidin D fluorescein (Vector Laboratories, diluted 1:300) for 2 h at room temperature, rinsed, coverslipped by using Vectashield (Vector Laboratories), and viewed by using a Bio-Rad MRC 600 confocal microscope. For double-labeling experiments the procedures are the same as described above except the cells were incubated with anti-CNA5 and antisynaptophysin (diluted 1:200) simultaneously. After rinsing, the cells were incubated in biotinylated anti-mouse IgG and anti-rabbit IgG Texas red (diluted 1:100), rinsed, incubated in avidin D Cy5 (diluted 1:300) and anti-rabbit IgG Texas red, and then rinsed and coverslipped as described above. Images were analyzed by using the METAMORPH (Universal Imaging, Downingtown, PA) image-analysis program and processed in PHOTOSHOP (Adobe Systems, Mountain View, CA) and CANVAS 5.03 (Deneba, Miami) . Control cultures included ones in which the primary antibody was omitted or replaced by normal rabbit serum. In both cases, no specific staining was observed.
Ca 2؉ Currents in SCGNs. Whole-cell patch-clamp recordings from cell bodies of SCGNs, 10-14 days in culture, were obtained by using standard techniques as described (25) . The currents were recorded with a Nihon Kohden CEZ whole-cell clamp amplifier and analyzed with the pCLAMP system (Axon Instruments, Foster City, CA) in the presence of 1.5 M tetrodotoxin (Sigma) and 10 M nifedipine (Sigma) to block Na ϩ currents and L-type Ca 2ϩ currents, respectively. The external solution contained 136 mM tetraethylammonium chloride, 5.94 mM CsCl, 10 mM CaCl 2 , 1.2 mM MgCl 2 , 11 mM glucose, and 10 mM Hepes (pH 7.4). Patch pipettes were filled with a solution consisting of 130 mM cesium acetate, 5 mM MgATP, 10 mM Hepes, and 10 mM EGTA (pH 7.3). Pipette resistance was 1.5-2.0 M⍀. -Agatoxin IVA and -conotoxin GVIA were obtained from Peptide Institute (Osaka).
Synaptic Transmission Between SCGNs. Conventional intracellular recordings were made from two neighboring neurons, cultured for 4-6 weeks, by using microelectrodes filled with 1 M potassium acetate (70-80 M⍀). Presynaptic neurons were selected by the fluorescence of dye in their nuclei. Excitatory postsynaptic potentials (EPSPs) were recorded from a neighboring neuron when action potentials were generated in the presynaptic neuron by passage of current through an intracellular recording electrode. EPSPs were recorded once every 20 s. Experiments were carried out at room temperature (25-27°C). Neurons were superfused with modified Kreb's solution consisting of 136 mM NaCl, 5.9 mM KCl, 8 mM CaCl 2 , 1.2 mM MgCl 2 , 11 mM glucose, and 3 mM Na-Hepes (pH 7.4). Superfusion was stopped after the application of Ca 2ϩ -channel blockers. Electrophysiological data were collected and analyzed by using software written by the late Ladislav Tauc (Centre National de la Recherche Scientifique, Gif sur Yvette, France). The peak amplitudes of EPSPs were measured and averaged. The resultant values were smoothed by an eight-point moving average algorithm and plotted against recording time with the normalized average EPSP amplitudes. is not highly selective among channel types. In the experiments described below, we use primarily -conotoxin GVIA and -agatoxin IVA to define the contribution of endogenous Ca v 2.2 channels and exogenously expressed Ca v 2.1 channels to synaptic transmission between SCGNs.
Results
Expression of Exogenous Ca 2؉ Channels in Cultured SCGNs. Expression of endogenous Ca 2ϩ channels in cultured SCGNs was assessed by immunocytochemistry with subunit-specific antibodies (24, 35, (38) (39) (40) . Ca v 1.2, Ca v 2.2, and Ca v 2.3 channels were observed in the cell bodies of these neurons ( Fig. 1 B-D) , consistent with electrophysiological recordings of L-, N-, and R-type Ca 2ϩ currents in these cells. Only Ca v 2.2 channels were observed in punctate clusters on cell bodies, as expected for the specific role of these channels in nerve terminals where they initiate transmitter release (Fig. 1B) . In contrast, Ca v 2.1 channels, which mediate P͞Q-type Ca 2ϩ currents, were not observed in these immunocytochemical studies of injected neurons (Fig. 1 A) .
To detect expression of exogenous Ca 2ϩ channels in nerve terminals of cultured SCGNs, we examined the distribution of Ca v 1.2, Ca v 2.1, and Ca v 2.3 channels in neurons injected with cDNAs encoding these ␣ 1 subunits [rbA-I (31), rbE-II (14) , and rbC-II, (7)]. The cDNAs were introduced, along with dextran fluorescein as a visual marker, into the nuclei of SCGNs. Twenty to 24 h later, the cultures were fixed with acetone or 4% paraformaldehyde for immunofluorescent staining with subunitspecific antibodies. Cell bodies of injected neurons express high amounts of all three ␣ 1 subunits (data not shown). In addition, the neighboring neurons to Ca v 2.1-injected SCGNs have many immunoreactive puncta representing immunostained nerve terminals with clusters of Ca v 2.1 channels (Fig. 1E , compare with Fig. 1 A) . Ca v 2.3-injected neurons have fewer nerve terminals that are immunostained (Fig. 1F) , and Ca v 1.2-injected neurons do not have any terminals that are immunostained (Fig. 1G) .
Ca v 2.1-immunostained puncta were shown to be nerve terminals by coimmunostaining with antibodies against the synaptic vesicle protein synaptophysin. Adjacent to the cell body shown in Fig. 1 H-J is an injected SCGN expressing Ca v 2.1, as indicated by labeling with fluorescein dextran and anti-CNA5 (data not shown). Double immunolabeling showed that Ca v 2.1-stained puncta on adjacent neurons (Fig. 1H ) overlapped or were closely colocalized with synaptophysin-stained puncta (Fig. 1I) . Merged images showed yellow puncta having similar stain intensity for the two proteins as well as red Ca v 2.1-stained puncta that were partially overlapping or closely colocalized with green synaptophysin-stained puncta (Fig. 1J) . The results of Fig. 1 show that the relative ability of expressed ␣ 1 subunits to be transported to nerve terminals is Ca v 2.1 Ͼ Ca v 2.3 Ͼ Ͼ Ca v 1.2. Although the levels of staining by different antibodies cannot be compared quantitatively, it appeared that more nerve terminals were immunostained intensely by antibodies against endogenous Ca v 2.2 (Fig. 1B) than by antibodies against exogenously expressed Ca v 2.1 or Ca v 2.3 ( Fig. 1 E and F) . These immunofluorescent staining results show that exogenous ␣ 1 subunits can be expressed in SCGNs and transported to nerve terminals, but they may not be present at the same density as endogenously expressed Ca v 2.2.
To confirm functional expression of exogenous P͞Q-type Ca (Fig. 2) . In noninjected neurons, the peak Ca 2ϩ currents, 440 Ϯ 53 pA (mean Ϯ SEM, n ϭ 6), were reduced to 85 Ϯ 5.1 pA (n ϭ 6) after bath application of -conotoxin GVIA at 5 M, a saturating concentration ( Fig. 2 A and C) . In contrast, peak Ca 2ϩ currents of 200 Ϯ 29 pA (n ϭ 7) were recorded in the ␣ 1 2.1-injected neurons in the presence of -conotoxin GVIA (Fig. 2 B and C) . Thus, -conotoxin GVIA-insensitive currents in the ␣ 1 2.1-injected neurons were 2.35-fold larger than in noninjected neurons. Additional bath application of -agatoxin IVA, a P͞Q-type Ca 2ϩ -channel blocker, at 250 nM reduced the -conotoxin GVIA-resistant currents in the ␣ 1 2.1-injected neurons to 93 Ϯ 32 pA (n ϭ 7). These results show that functional -agatoxin IVA-sensitive P͞Q-type Ca 2ϩ channels were expressed in the ␣ 1 2.1-injected neurons, presumably through association with endogenous ␤, ␥, and ␣ 2 ␦ subunits, which are known to be expressed in SCGNs.
-Agatoxin IVA-Sensitive Synaptic Transmission Induced by Expression of Cav2.1 cDNA. To assess the contribution of newly expressed P͞Q-type Ca 2ϩ currents at presynaptic terminals to release of the transmitter acetylcholine, SCGNs in culture for 4-6 weeks were injected with Ca v 2.1 cDNA, and synaptic transmission was examined 20-24 h later in the presence of N-or P͞Q-type Ca 2ϩ -channel blockers (Fig. 3) by recording EPSPs evoked by presynaptic action potentials once every 20 s (25, 33, 41 ). -Conotoxin GVIA reduced amplitudes of EPSPs to 23 Ϯ 7% (n ϭ 5) at 10 min after bath application of 2.5 M toxin to synapses where the presynaptic neurons were injected with ␣ 1 2.1 ( Fig. 3 A and B) . The rates of rise and decay of the EPSP were very similar, although the rise time was slightly shorter after -conotoxin GVIA (Fig. 3A) . The addition of three more doses of 2.5 M -conotoxin GVIA had little further effect, reducing EPSPs to 17 Ϯ 4% (n ϭ 5; Fig. 3B ). The addition of 250 nM -agatoxin IVA inhibited the remaining synaptic transmission (Fig. 3B) , demonstrating that the injected P͞Q-type Ca 2ϩ channels can mediate synaptic transmission. The EPSPs remaining in the presence of 5 M -conotoxin GVIA were abolished completely by -agatoxin IVA at 250 M (Fig. 3C ). In the ␣ 1 2.1-injected neurons, EPSPs were reduced to 71 Ϯ 6% (n ϭ 5) at 15 min by treatment with 250 nM -agatoxin IVA without prior treatment with -conotoxin GVIA (Fig. 3D) . Therefore, Ϸ30% of the synaptic transmission in injected neurons is initiated by expressed P͞Q-type Ca 2ϩ channels. In uninjected neurons, synaptic transmission was inhibited completely by -conotoxin GVIA but was unaffected by -agatoxin IVA (Fig. 3 E and F) . Thus, the agatoxin IVA-sensitive synaptic transmission in injected neurons is mediated entirely by exogenously expressed P͞Q-type Ca 2ϩ channels. currents mediate synaptic transmission less efficiently than N-or P͞Q-type Ca 2ϩ currents in synapses where they are expressed together such as the calyx synapses of the medial nucleus of the trapezoid body (20, 24) . To examine the ability of exogenously expressed R-type Ca 2ϩ channels to initiate synaptic transmission at SCGN synapses, cDNA encoding rat brain Ca 2ϩ channel ␣ 1 2.3 subunits was introduced into presynaptic neurons, and synaptic transmission was studied 20-24 h later. SNX-482 or Ni 2ϩ was used to block R-type Ca 2ϩ currents (14, 42) . EPSP amplitude was reduced to 90 Ϯ 5% (n ϭ 6) at 10 The peak amplitude of EPSP with -conotoxin GVIA (blue trace) was normalized to that of the control EPSP before adding -conotoxin GVIA (black trace). The time constant () for rate of rise, 5.6 Ϯ 1.0 ms (n ϭ 3), was decreased by -conotoxin GVIA to 4.7 Ϯ 0.7 ms.
Synaptic Transmission in Neurons Expressing
for rate of fall, 35.0 Ϯ 11.4 ms (n ϭ 3), was slightly decreased by -conotoxin GVIA, 26.5 Ϯ 5.2 ms. (B) EPSPs were recorded from Cav2.1-injected synapses (n ϭ 5). -Conotoxin GVIA was applied additively every 15 min. -Agatoxin IVA was added in the presence of 10 M -conotoxin GVIA. (C) EPSP amplitudes were recorded from ␣12.1-expressing synapses in the presence of -conotoxin GVIA at 5 M (n ϭ 6). -Agatoxin IVA was applied at t ϭ 0. (D) EPSPs were recorded from ␣12.1-expressing synapses (n ϭ 5). -Agatoxin IVA was applied at t ϭ 0. (E) As a control, -conotoxin GVIA was applied additively to control synapses (n ϭ 5). (F) As a control, -agatoxin IVA was applied to control synapses at t ϭ 0 (n ϭ 5). PSP, postsynaptic potential. min after bath application of 100 nM SNX-482 in Ca v 2.3-expressing synapses (Fig. 4A ), but the toxin had no effect on nonexpressing synapses (97 Ϯ 5% at 10 min; Fig. 4D ). After block of endogenous N-type Ca 2ϩ currents by -conotoxin GVIA, Ϸ10% of the EPSP amplitude remained and could be inhibited by 150 M Ni 2ϩ (Fig. 4B) . In contrast, -agatoxin IVA had no effect on neurons injected with Ca v 2.3 (Fig. 4C) . These results indicate that the effect of -agatoxin IVA is specific for synaptic transmission at Ca v 2.1-injected synapses and has no effect on the Ca v 2.3-injected synapses. Expression of exogenous Ca v 2.3 channels is less efficient in supporting synaptic transmission than expression of Ca v 2.1 channels.
Synaptic Transmission in Neurons Expressing Exogenous Cav1.2 Channels.
To test the contribution of L-type Ca 2ϩ channels to acetylcholine release at the SCGN synapses, Ca v 1.2 subunits were expressed in presynaptic neurons. As expected from the immunocytochemical results (Fig. 1) , bath application of nifedipine at 2.5 M did not affect synaptic transmission in the injected synapses (97 Ϯ 7%, n ϭ 4, at 15 min; Fig. 5A ) or in control synapses (96 Ϯ 8%, n ϭ 6, at 15 min; Fig. 5C ). As a control for toxin specificity, we confirmed that -agatoxin IVA (250 nM) produced no effect on synaptic transmission at the Ca v 1.2-injected synapses (96 Ϯ 6%, n ϭ 6, at 15 min; Fig. 5B ). These results provide further evidence that the inhibitory effect of -agatoxin IVA on synaptic transmission is specific for the Ca v 2.1-injected synapses but not for the synapses expressing the other ␣ 1 subunits.
Discussion
SCGNs as Expression Hosts. SCGNs have been reported as mammalian expression hosts for G proteins and receptors for neurotransmitters (34, 43, 44) . Cytoplasmic injection of cRNA (34, 44) or nuclear injection of cDNA (43) nifedipine, -conotoxin GVIA, and -agatoxin IVA have been reported (45 (24) .
Reconstitution of Neurotransmission Correlates with Nerve-Terminal
Localization. The specific role of Ca v 2 channels in fast neurotransmission might be due to their specific trafficking to nerve terminals, specific functional properties and protein-protein interactions within nerve terminals, or both. The results presented here show a close correlation between the ability of different Ca v channel subtypes to be localized to nerve terminals and their effectiveness in reconstitution of neurotransmission. Thus, in this cell system, differential trafficking of Ca v 2 channels to nerve terminals is a key determinant of their effectiveness in synaptic transmission.
Our results indicate that the exogenous P͞Q-and R-type Ca 2ϩ channels expressed in SCGNs function in concert with native N-type Ca 2ϩ channels in acetylcholine release, because synaptic transmission was blocked additively by -conotoxin GVIA, -agatoxin IVA, and Ni ϩ . Evidently, molecular features of Ca v 2 but not Ca v 1.2 channels are essential for transport and concentration at nerve terminals of SCGNs. Cholinergic synapses formed by injected SCGNs in culture are an effective system to study the molecular basis for the specific function of Ca 2ϩ -channel subtypes in synaptic transmission.
